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Abstract The mechanisms underlying membrane-type-1 matrix
metalloproteinase (MT1-MMP)-dependent induction of cell
migration were investigated. Overexpression of MT1-MMP
induced a marked increase in cell migration, this increase being
dependent on the presence of the cytoplasmic domain of the
protein. MT1-MMP-dependent migration was inhibited by a
mitogen-activated protein kinase kinase 1 inhibitor, suggesting
the involvement of the extracellular signal-regulated protein
kinase (ERK) cascade in the induction of migration. Accordingly,
MT1-MMP overexpression induced the activation of ERK, this
process being also dependent on the presence of its cytoplasmic
domain. MT1-MMP-induced activation of both migration and
ERK required the catalytic activity of the enzyme as well as
attachment of the cells to matrix proteins. The MT1-MMP-
dependent activation of ERK was correlated with the activation
of transcription through the serum response element, whereas
other promoters were unaffected. Taken together, these results
indicate that MT1-MMP trigger important changes in cellular
signal transduction events, leading to cell migration and to gene
transcription, and that these signals possibly originate from the
cytoplasmic domain of the protein. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Cell migration represents an essential process for a variety
of biological events, including embryonic development, in-
£ammatory responses, angiogenesis and tumor metastasis
[1]. In this latter case, it is well established that cell invasion
requires remodeling of the extracellular matrix through acti-
vation of both serine proteases and matrix metalloproteinases
(MMPs) [2]. The localization of these proteases at the cellular
surface appears to be a general strategy essential for the fo-
cusing of the degradative processes underlying tumor invasion
[3]. While this association can occur through binding to spe-
ci¢c receptors or integrins [3,4], the identi¢cation of a sub-
family of MMP, the membrane-type MMPs (MT-MMP), that
are intrinsically anchored to the cell membrane, has driven
considerable interest [5]. MT-MMPs are unique among the
members of the MMP family in that they contain a trans-
membrane domain that allows their localization to the cell
surface as well as a short cytoplasmic tail of still unknown
function. Six members of this family have been described to
date, MT1-MMP being the most studied so far (reviewed in
[6,7]). Expression of MT1-MMP at the cell surface promotes
the activation of proMMP-2, leading to the hypothesis that
the function of MT1-MMP is to regulate the activity of
MMP-2 and the resulting tumor invasion [6,7]. There is how-
ever increasing genetic and biochemical evidences that MT1-
MMP plays additional roles in both normal cell function as
well as in tumor cell migration and invasion. Gene disruption
of MT1-MMP results in severe abnormalities in bone forma-
tion, angiogenesis and collagen turnover, leading to the devel-
opment of dwar¢sm, arthritis and premature death [8,9]. Since
MMP-2 null mice do not show these defects [10], these obser-
vations suggest that MT1-MMP has other biological func-
tions in addition to its role in proMMP-2 activation. Such a
role was exempli¢ed by studies showing an essential role for
MT1-MMP in ¢brinolysis [11]. More recently, overexpression
of MT1-MMP was shown to potentiate invasion of collagen
basement membranes by epithelial cells [12] as well as the
migratory potential of glioma [13], melanoma [14], breast
[15] and colon cancer cells [16].
We have recently shown that MT1-MMP was predomi-
nantly localized to caveolae [17], small plasma membrane do-
mains that contain a very high proportion of signal-transduc-
ing proteins, suggesting that MT1-MMP-stimulated cellular
processes may involve the activation of intracellular signaling
events. Indeed, the present report presents evidence that MT1-
MMP-dependent cell migration is correlated with an induc-
tion of the extracellular signal-regulated protein kinase (ERK)
cascade, leading to an increase in gene transcription under the
control of the serum response element (SRE). These results
strengthen the hypothesis that the role of MT1-MMP in tu-
mor progression is not strictly restrained to its classical role in
activation of proMMP-2 but also to the induction of intra-
cellular signaling pathways.
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2. Materials and methods
2.1. Materials
COS-7 cells were cultured under an air:CO2 (19:1) atmosphere in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal calf serum, 4 mM glutamine, 100 IU/ml penicillin
and 100 Wg/ml streptomycin. The conditioned media (CM) from
U87 glioma cells, containing proMMP-2, was prepared as described
[18]. Transwells (8-Wm pore size) used for cell migration were from
Costar. All products for electrophoresis and zymography were pur-
chased from Bio-Rad. The various inhibitors used in the study were
from Biomol. Human recombinant tissue inhibitor of MMP1 (TIMP-
1) and TIMP-2 were kindly provided by R. Fridman (Detroit, MI,
USA). The anti-MT1-MMP polyclonal antibodies (raised against the
hinge region) were from Chemicon. Antibodies against phospho-ERK
(Thr202/Tyr204) and ERK were purchased from Cell Signaling Tech-
nology, New England Biolabs. Horseradish peroxidase-conjugated
donkey anti-rabbit or anti-mouse IgG were obtained from Jackson
Immunoresearch Laboratories.
2.2. Cloning and transfection of MT1-MMP constructs
The cDNA encoding full-length human MT1-MMP was generated
as previously described [17,18]. Transmembrane domain-deleted as
well as cytoplasmic deletion mutants of MT1-MMP were generated
by polymerase chain reaction (PCR), using wild-type MT1-MMP as
the template and anti-sense primers annealing to the desired sequen-
ces. Three di¡erent cytoplasmic mutants were synthesized: MT1-
MMP(Cv20), in which the entire cytoplasmic domain is deleted,
MT1-MMP(Cv16), containing the sequence RRHV and MT1-
MMP(Cv10), containing the sequence RRHGTPRRLV. The C-termi-
nal valine residue was included in the PCR primers in order to allow
tra⁄cking of the MT1-MMP mutants to the plasma membrane [19].
The catalytically inactive mutant MT1-MMP(E240A) was generated
by PCR, using the overlap extension method [20]. The PCR products
were cloned into pcDNA3.1 TOPO (Invitrogen) and the identity of all
constructs was con¢rmed by DNA sequencing. The transient trans-
fection of the plasmids in subcon£uent COS-7 cells was performed
using the non-liposomal formulation FUGENE-6 transfection reagent
(Roche Molecular Biochemicals). The expression levels of the various
MT1-MMP constructs were monitored by immunoblotting and acti-
vation of proMMP-2 to its active form by COS-7 cells transfected
with the various MT1-MMP cDNAs was monitored by gelatin zy-
mography [17,18].
2.3. Cell migration assays
COS-7 cell migration was performed using transwells (Costar; 8-Wm
pore size) precoated with 0.5% gelatin/phosphate-bu¡ered saline, as
described [17]. The transwells were assembled in 24-well plates (Fal-
con 3097) and the lower chambers ¢lled with 600 Wl of DMEM sup-
plemented with 10% fetal calf serum. For the study of the e¡ect of
MT1-MMP on cell migration, cells were transfected with the various
MT1-MMP constructs and allowed to recover for 48 h. Cells were
harvested by trypsinization, spun down, resuspended in 100 Wl fresh
DMEM media at 7.5U105 cells/ml, and inoculated into the upper
chamber of each transwell. For inhibition studies, cells were preincu-
bated for 2 h at 37‡C with the inhibitors, spun down to remove the
inhibitor from the media, and resuspended to the same cell density.
The plates were then placed at 37‡C in 5% CO2/95% air for 2 h. Cells
that had migrated to the lower surface of the ¢lters were ¢xed, stained
with 0.1% crystal violet/20% MeOH, and counted. Data are presented
as the average number of migrated cells per ¢ve ¢elds (U100).
2.4. Activation of ERK by MT1-MMP
COS-7 cells were transfected with either empty vector (pcDNA3.1),
wild-type or mutated versions of MT1-MMP as described above and
the cells were allowed to recover for 48 h. Cells were then trypsinized,
washed and incubated with gentle agitation for 1 h in the presence of
0.1% bovine serum albumin (BSA). The resulting cells were then ei-
ther kept in suspension or plated on dishes coated with gelatin or
poly-L-lysine and incubated for an additional 2 h at 37‡C.
For the preparation of whole cell lysates, cells were resuspended in
a bu¡er containing 1% Triton X-100, 0.5% Nonidet P-40, 150 mM
NaCl, 100 WM sodium vanadate, 10 mM NaF and 20 mM Tris^HCl
(pH 7.4). The mixture was incubated on ice for 30 min and insoluble
matter was removed by centrifugation. Equal amounts of proteins
from control and treated cells were resuspended in sample bu¡er
and separated by sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis using 9% acrylamide gels. After electrophoresis, proteins
were electrotransferred to a 0.45-Wm pore size polyvinylidene di£uo-
ride membrane using a Milliblot graphite electroblotter (Millipore),
blocked overnight at 4‡C with 5% non-fat dry milk in Tris-bu¡ered
saline (150 mM NaCl, 20 mM Tris^HCl, pH 7.5) containing 0.3%
Tween-20 and incubated with the anti-phospho-speci¢c ERK
(Thr202/Tyr204) antibodies. Blots were then incubated with horserad-
ish peroxidase-conjugated anti-rabbit IgG (1/10 000 dilution) and im-
munoreactive material was visualized by enhanced chemilumines-
cence.
2.5. Gene reporter assays
The Mercury Pathway Pro¢ling System, in which a secreted form of
alkaline phosphatase (SEAP) is fused to promoters activated by di¡er-
ent responsive elements, was used. Cells were transfected with the
various constructs and aliquots of the CM were collected at di¡erent
times. SEAP activity was measured by the hydrolysis of p-nitrophenyl
phosphate (pNPP), as described by the manufacturer (Clontech).
Fig. 1. The cytoplasmic domain of MT1-MMP is important for cell
migration but not for proMMP-2 activation. A: COS-7 cells were
transfected as described above and incubated for 24 h in the pres-
ence of an exogenous source of proMMP-2 (conditioned medium
(CM) from U87 cells [17]). ProMMP-2 activation was monitored by
gelatin zymography (lower panel). The expression levels of the vari-
ous MT1-MMP constructs were monitored by Western blotting us-
ing anti-MT1-MMP polyclonal antibodies. B: COS-7 cells were
transfected with either empty vector (Ctl) or with the various MT1-
MMP constructs and allowed to recover for 48 h. Transfected cells
were harvested, seeded in Boyden chambers coated with gelatin and
incubated for 2 h. Cells that have migrated were visualized by stain-
ing and microscopy. Five di¡erent microscopic ¢elds were counted
for all conditions. Results are the means þ S.D. of six distinct ex-
periments performed in triplicate.
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3. Results
3.1. Overexpression of MT1-MMP induces cell migration
MT1-MMP has recently been shown to play an important
role in the migration of various cell types [12^17]. In order to
determine the mechanisms involved in MT1-MMP-dependent
migration of COS-7 cells, we ¢rst compared the ability of
various overexpressed MT1-MMP constructs to induce
proMMP-2 activation as well as cell migration. COS-7 cells
were transiently transfected with wild-type MT1-MMP, the
catalytically inactive mutant E240A, or with three distinct
cytoplasmic domain-truncated versions of the enzyme: MT1-
MMP(Cv20), in which the entire cytoplasmic domain is de-
leted, MT1-MMP(Cv16), containing the sequence RRHV and
MT1-MMP(Cv10), containing the sequence RRHGTPRRLV.
The extent of proMMP-2 activation was monitored by gelatin
zymography, whereas cell migration was assessed by a modi-
¢ed Boyden chamber assay. As shown in Fig. 1A, overexpres-
sion of native as well as of the truncated mutants of MT1-
MMP all induced a marked activation of an exogenous source
Fig. 2. MT1-MMP-dependent cell migration is inhibited by TIMP-2
and a MEK1 inhibitor. A: E¡ect of inhibitors on proMMP-2 acti-
vation and cell migration. COS-7 cells transfected with wild-type
MT1-MMP were incubated for 24 h in the presence of an exoge-
nous proMMP-2 in the absence (Ctl) or presence of the indicated
inhibitors. These include TIMP-1, TIMP-2 (100 ng/ml each),
PD98059 (50 WM), SB203580 (10 WM), and calphostin C (100 nM).
ProMMP-2 activation is expressed as the percentage of MMP-2 in
the active form, as determined by laser densitometry of the zymo-
grams. Results are the means þ S.D. of three experiments. For cell
migration, transfected COS-7 cells were preincubated for 1 h with
the indicated inhibitors, harvested and seeded in Boyden chambers.
The extent of migration was assessed as described in Fig. 1, follow-
ing a 2 h incubation. The means þ S.D. of three experiments per-
formed in triplicate are presented. B: E¡ect of PD98059 on basal
and MT1-MMP-dependent migration. Mock- (open circles) or
MT1-MMP-transfected cells (¢lled circles) were preincubated with
various concentrations of PD98059 and subjected to migration as-
says. The means of two experiments performed in triplicate are pre-
sented.
Fig. 3. MT1-MMP promote activation of the ERK cascade and of
gene transcription. A: Cells were transfected with the various MT1-
MMP constructs and allowed to recover for 48 h. Cells were har-
vested in lysis bu¡er and 20 Wg of proteins were loaded on a 9%
polyacrylamide gel. The activation of ERK was visualized using
anti-phospho-speci¢c-ERK antibodies (upper panel) whereas total
ERK was detected using a monoclonal ERK antibody. A represen-
tative experiment is shown. B: Cells were co-transfected with plas-
mids containing the indicated response elements and with either
empty vector (pcDNA3.1) or wild-type MT1-MMP and cells were
allowed to recover for 48 h in serum-free medium. Aliquots of the
resulting conditioned medium were used to measure alkaline phos-
phatase activity, using pNPP as the substrate. SEAP indicates a
control vector in which SEAP is constitutively secreted by the cells.
C: Cells were co-transfected with the indicated MT1-MMP con-
structs and with the SRE-SEAP plasmid and cells were allowed to
recover for 48 h in serum-free medium. The extent of gene tran-
scription driven by the SRE was monitored as described above.
Transcription driven by the presence of 5% serum is presented to in-
dicate the maximal transcription achieved under these conditions.
Results are means þ S.D. of ¢ve distinct experiments.
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of proMMP-2. As expected, this activation was however not
observed in cells expressing the catalytically inactive E240A
mutant. Truncation of the transmembrane domain of the pro-
tein resulted in the secretion of MT1-MMP in the CM with a
concomitant loss of its ability to activate proMMP-2, as re-
ported previously [21].
The e¡ects of some of these mutants on cell migration were
however very distinct. As reported in a number of recent re-
ports [12,14,15,17], overexpression of full-length MT1-MMP
promoted a marked increase in the migratory potential of
COS-7 cells (Fig. 1B). However, MT1-MMP-dependent mi-
gration was signi¢cantly reduced in the Cv16 mutant and
was completely abolished in the Cv20 mutant in which the
cytoplasmic domain is completely removed (Fig. 1B). Similar
results were obtained when these di¡erent constructs were
transfected into bovine aortic endothelial cells (not shown).
These results suggest that MT1-MMP-dependent activation
of proMMP-2 is not su⁄cient to trigger cell migration, this
process also requiring the presence of the cytoplasmic domain
of the protein.
3.2. Pharmacological inhibition of MT1-MMP-induced
migration
We next investigated whether inhibition of MT1-MMP-de-
pendent proMMP-2 activation was correlated with the inhibi-
tion of MT1-MMP-dependent cell migration. Transfected
COS-7 cells were preincubated with a number of pharmaco-
logical inhibitors speci¢c to various signaling pathways and
the extent of proMMP-2 activation or cell migration was
monitored. As shown in Fig. 2A, addition of recombinant
TIMP-2 to the transfected cells markedly reduced proMMP-
2 activation, whereas TIMP-1 was ine¡ective to inhibit this
process. TIMP-2 also strongly inhibited MT1-MMP-depen-
dent migration (Fig. 2A). In addition, preincubation of the
cells with PD98059, a well-characterized MEK1 inhibitor,
strongly inhibited MT1-MMP-dependent migration, while
this compound had no e¡ect on proMMP-2 activation. Inhi-
bition of protein kinase C by calphostin C, or of the stress-
activated protein kinase p38 by SB203580 were without e¡ect
on both processes, as were inhibition of protein kinases A and
G (results not shown).
Interestingly, inhibition by PD98059 was speci¢c to MT1-
MMP-driven migration since this compound had negligible
e¡ect on basal, MT1-MMP-independent migration of COS-7
cells (Fig. 2B). This suggests that MT1-MMP-dependent mi-
gration involves a speci¢c activation of MEK1.
3.3. MT1-MMP induces activation of ERK and of
gene transcription.
The inhibitory e¡ect of PD98059 on MT1-MMP-dependent
cell migration led us to examine the potential activation of the
ERK pathway by MT1-MMP, as well as the role of the cy-
toplasmic domain of the protein in this process. As shown in
Fig. 3A, overexpression of full-length MT1-MMP in COS-7
cells induced a marked increase in the amounts of active,
dually phosphorylated (Thr202/Tyr204) p44/p42 ERK in
whole cell lysates, as monitored with phospho-speci¢c ERK
antibodies. This increase appears speci¢c for ERK since MT1-
MMP overexpression had no e¡ect on p38 (data not shown).
This increase in pERK levels by wild-type MT1-MMP was
not observed upon overexpression of the catalytically inactive
E240A mutant or of the cytoplasmic-deleted versions of MT1-
MMP (Fig. 3A). This suggests that both the catalytic activity
and the cytoplasmic domain of MT1-MMP are important for
the induction of ERK.
In parallel experiments, we examined whether this increase
in ERK activation could be correlated with the activation of
gene transcription, a well-characterized intracellular conse-
quence of ERK activation. Cells were co-transfected with
wild-type MT1-MMP in the absence (pcDNA3.1) or in the
presence of plasmids containing di¡erent response elements
fused to SEAP. In this gene reporter assay, the activity of
the response elements can be easily monitored by measuring
SEAP activity in the culture medium. Under these conditions,
we observed that co-transfection of full-length MT1-MMP
with these constructs induced signi¢cant activation of the
Fig. 4. MT1-MMP-induced activation of migration and of ERK re-
quires cell adhesion. A: COS-7 cells were transfected with either
pcDNA3.1 or wild-type MT1-MMP and cells were allowed to re-
cover under serum-free conditions for 24 h. Cells were harvested
and seeded into Boyden chambers that had been coated with the in-
dicated matrix proteins. The extent of cell migration was assessed as
described. A representative experiment is shown. B: Cells were
transfected with either pcDNA3.1 or with the wild-type, E240A and
Cv20 versions of MT1-MMP. After recovery, cells were either kept
in suspension by 1 h gentle rocking in serum-free medium contain-
ing 0.1% BSA or plated on dishes coated with either poly-L-lysine
or gelatin. After a 2-h incubation, cells were collected, lysed and
subjected to electrophoresis and immunoblotting with pERK and
ERK antibodies. A representative experiment is shown.
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SRE (Fig. 3B), whereas it had no detectable e¡ects on the
activity of other elements or on the control SEAP plasmid.
This induction of SRE activity required the presence of the
entire cytoplasmic domain of the protein since it was not
observed in any of the three deletion mutants (Fig. 3C). In
addition, the E240A mutant did not promote gene transcrip-
tion, suggesting the requirement of the catalytic activity of the
enzyme for the induction of these events by MT1-MMP.
The participation of serum- and matrix-derived factors to
the induction of cell migration and ERK activation by MT1-
MMP was also investigated. Under our experimental condi-
tions, the induction of cell migration by MT1-MMP required
the presence of serum (not shown). In addition, the stimula-
tion of migration required the attachment of the cells to ma-
trix proteins, MT1-MMP-dependent migration being maximal
on ¢bronectin-, gelatin- and collagen-coated dishes (Fig. 4A).
This behavior was not related to an increased adhesion of
transfected cells to the matrix proteins, as determined in par-
allel cell attachment assays (results not shown). A similar
requirement for matrix proteins was also observed for the
induction of ERK. MT1-MMP-transfected cells kept in sus-
pension were unable to activate ERK, whereas plating of the
cells on gelatin-coated dishes induced a marked increase in
ERK activation compared to the mock-transfected cells
(Fig. 4B). Non-speci¢c and integrin-independent attachment
of the MT1-MMP-transfected cells to poly-L-lysine had no
e¡ect on ERK activation. These results imply that MT1-
MMP co-operates with both serum- and matrix-derived sig-
nals to induce migration and activation of ERK in cells.
4. Discussion
Cell migration is an highly co-ordinated process involving
the interplay of a variety of signaling pathways [1]. Among
these, activation of the ERK cascade has been shown to play
a critical role in the signaling events leading to cell migration
[22^24]. These considerations prompted us to examine the
involvement of this signaling pathway in cell migration in-
duced by MT1-MMP.
Under our experimental conditions, activation of ERK is
apparently essential for MT1-MMP-promoted cell migration
since the mitogen-activated protein (MAP) kinase kinase
(MEK) inhibitor, PD98059, completely blocked the e¡ect of
overexpressed MT1-MMP without a¡ecting the basal level of
migration. The catalytic activity of MT1-MMP appears im-
portant for the ability of the protein to induce both cell mi-
gration and activation of ERK since these processes were
markedly reduced by addition of exogenous TIMP-2, but
not TIMP-1, as well as by a point mutation within the cata-
lytic domain of the enzyme. However, our results also show
that the catalytic activity of MT1-MMP is not su⁄cient per se
for the e¡ects reported here since cytoplasmic domain-deleted
mutants still retained the ability to activate proMMP-2 but
failed to induce cell migration and ERK activation. These
results thus suggest that the cytoplasmic domain of MT1-
MMP represents a crucial region of the protein involved in
both cell migration and activation of the ERK cascade. A
similar requirement for the cytoplasmic region was recently
described for the MT1-MMP-dependent invasion by melano-
ma and breast carcinoma cells [15]. In this latter case, a single
point mutation of a cysteine residue located in the cytoplasmic
segment of the protein (C574) was su⁄cient to inhibit cell
migration and invasion, possibly by abolishing the formation
of MT1-MMP dimers [15]. Under our experimental condi-
tions, however, removal of this cysteine residue (MT1-
MMP(Cv10)) did not signi¢cantly a¡ect migration but com-
pletely abolished activation of ERK. The reason for this dis-
crepancy is unclear but may suggest that additional signals
originating from the cytoplasmic domain of MT1-MMP
may contribute to the biological e¡ects triggered by this en-
zyme. Close examination of this sequence, however, indicates
that it is devoid of known catalytic activities, suggesting that
it may provide signals by recruiting and/or binding other pro-
teins or messenger molecules, leading to cell migration and
activation of the ERK cascade. In this respect, it is notewor-
thy that the sequence RHGTPRR present in the MT1-MMP
cytoplasmic domain shows signi¢cant homology with the
KXGFFKR sequence of integrin K subunits [25]. This se-
quence has been shown to be involved in the interaction of
K integrin with proteins such as calreticulin [26] and the gua-
nine nucleotide exchange protein Mss4 [27]. It is thus tempt-
ing to speculate that the binding of speci¢c proteins to this
region of MT1-MMP could trigger the changes observed in
ERK activation and transcription. This interaction would
however require the catalytic activity of the enzyme since
these processes are abolished by either endogenous inhibitors
of MT1-MMP (e.g. TIMP-2) or by a catalytically mutated
form of the enzyme. The binding of the enzyme to matrix
proteins may thus induce conformational changes within its
structure that may lead to its interaction with these proteins,
triggering activation of the ERK cascade. The observation
that MT1-MMP-dependent activation of migration and of
ERK requires adhesion of cells to matrix-coated dishes
strongly support this hypothesis.
The matrix requirement for the MT1-MMP-dependent ef-
fects also suggest a potential role of integrins in the regulation
of MT1-MMP activity. Activation of the ERK cascade in
response to integrin-mediated cell adhesion has been widely
described (for a review see [28]). In this context, it is interest-
ing to note that MT1-MMP and KvL3 are co-localized on the
cell membrane of tumor cells [29,30] and that KvL3 co-operate
with MT1-MMP for e⁄cient activation of MMP-2 [31]. It is
thus tempting to speculate that MT1-MMP may co-operate
with integrins in order to mediate its e¡ects on migration and
ERK activation. Alternatively, MT1-MMP-dependent cleav-
age of cell surface proteins, such as the hyaluronan receptor
CD44 and tissue transglutaminase was recently suggested to
play an important role in the induction of cell migration by
MT1-MMP [32,33] and it will be interesting to determine
whether the cleavage of such proteins is required for the in-
duction of the ERK cascade reported here.
The activation of ERK by MT1-MMP also seems to have
important e¡ects on gene transcription since transient trans-
fection of a reporter vector containing SRE, a cis-acting DNA
response element that can be activated through the MAPK/
JNK pathway [34], induced a marked increase in the activity
of this element. This e¡ect of MT1-MMP appears speci¢c, as
no activation of other response elements was detected under
our experimental conditions, and also requires the catalytic
activity and cytoplasmic domain of the protein. While the
e¡ects of MT1-MMP on gene transcription remain to be fur-
ther characterized, it is interesting to note that transgenic mice
overexpressing the MT1-MMP gene show increased mam-
mary gland abnormalities and adenocarcinoma [35] and that
FEBS 25379 19-10-01
D. Gingras et al./FEBS Letters 507 (2001) 231^236 235
overexpression of MT1-MMP in a gastric cancer cell line en-
hances lymph node metastasis of these cells [36]. Further stud-
ies aimed at the identi¢cation of genes whose expression is
altered upon overexpression of MT1-MMP should help to
determine the importance of MT1-MMP-driven gene tran-
scription in tumor cell growth and metastasis.
In summary, our results suggest that MT1-MMP-dependent
cell migration is correlated with the activation of the ERK
cascade, these processes being highly dependent on the cata-
lytic activity of the enzyme as well as on the cytoplasmic
domain of the protein. Further studies aimed at the identi¢-
cation of the cellular proteins that interact with the cytoplas-
mic domain of MT1-MMP should provide important infor-
mation on the mechanisms involved in these novel signal-
transducing properties of MT1-MMP.
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